Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections

ClinicalTrials.gov ID: NCT01339091

Public ClinicalTrials.gov record NCT01339091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Dalbavancin to a Comparator Regiment (Vancomycin and Linezolid) for the Treatment of Acute Bacterial Skin and Skin Structure Infections

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary object is to compare the early clinical efficacy (after 48-72 hours of therapy) of dalbavancin to the comparator regimen (vancomycin with the option to switch to oral linezolid) for the treatment of patients with a suspected or proven gram-positive bacterial skin or skin structure infection.

Study identification

NCT ID
NCT01339091
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
573 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2011 (Type not available)
Primary completion
Sep 2012 (Actual)
Completion
Nov 2012 (Actual)
Last update posted
Jan 31, 2014

2011 – 2012

United States locations

U.S. sites
55
U.S. states
16
U.S. cities
53
Facility City State ZIP Site status
Durata Study Site Anaheim California 92804 —
Durata Study Site Azusa California 91702 —
Durata Study Site Bellflower California 90706 —
Durata Study Site Buena Park California 90620 —
Durata Study Site Carmel California 46032 —
Durata Study Site Chula Vista California 92911 —
Durata Study Site Covina California 91723 —
Durata Study Site Fountain Valley California 92708 —
Durata Study Site La Mesa California 91942 —
Durata Study Site Long Beach California 90813 —
Durata Study Site Los Alamitos California 90720 —
Durata Study Site Los Angeles California 90015 —
Durata Study Site Oceanside California 92056 —
Durata Study Site Palm Desert California 92211 —
Durata Study Site Pasadena California 91105 —
Durata Study Site Sacramento California 95817 —
Durata Study Site San Diego California 92120 —
Durata Study Site Santa Ana California 92701 —
Durata Study Site Sylmar California 91342 —
Durata Study Site Torrance California 90509 —
Durata Study Site Upland California 91786 —
Durata Study Site Whittier California 90602 —
Durata Study Site Miami Florida 33144 —
Durata Study Site Miami Florida 33155 —
Durata Study Site Orlando Florida 32837 —
Durata Study Site Saint Cloud Florida 34769 —
Durata Study Site Tampa Florida 33613 —
Durata Study Site Columbus Georgia 31904 —
Durata Study Site Savannah Georgia 31406 —
Durata Study Site Idaho Falls Idaho 83404 —
Durata Study Site Pocatello Idaho 83202 —
Durata Study Site Moline Illinois 61265 —
Durata Study Site Rock Island Illinois 31201 —
Durata Study Site Baton Rouge Louisiana 70808 —
Durata Study Site Lafayette Louisiana 70503 —
Durata Clinical Site New Orleans Louisiana 70112 —
Durata Study Site Opelousas Louisiana 70570 —
Durata Study Site Detroit Michigan 48202 —
Durata Study Site Minneapolis Minnesota 55422 —
Durata Study Site Las Vegas Nevada 89109 —
Durata Study Site Somers Point New Jersey 08244 —
Durata Study Site Buffalo New York 14215 —
Durata Study Site Lake Success New York 11042 —
Durata Study Site New Hyde Park New York 11040 —
Durata Study Site Staten Island New York 10305 —
Durata Study Site The Bronx New York 10467 —
Durata Study Site Winston-Salem North Carolina 27103 —
Durata Study Site Columbus Ohio 43215 —
Durata Study Site Lima Ohio 45801 —
Durata Study Site Toledo Ohio 43608 —
Durata Study Site Pittsburgh Pennsylvania 15213 —
Durata Study Site Houston Texas 77030 —
Durata Study Site Houston Texas 77036 —
Durata Study Site Madison Wisconsin 53717 —
Durata Study Site Middleton Wisconsin 53562 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01339091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 31, 2014 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01339091 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →